PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...

Avoid false market narratives in 2026: why Exxon, Chevron & COP face oil oversupply risk, while AI-driven tech stays bullish.

Joseph Vandello, a psychology professor at the University of South Florida, says that when influential figures ramp up a ...